CS

Chandra Sekhar Rao Juvvadi

Active Director Director DIN 07539752
DIN 07539752 First appointment Jun 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Jun 2016
Shareholding value •••• Premium profile

About Chandra Sekhar Rao Juvvadi

Data last updated:

Chandra Sekhar Rao Juvvadi is a Director at Biozen Biologics Private Limited (since 2023), Director at Kriscon Infratech Private Limited (since 2016) and Director at Terramax Properties Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Pharma, Information Technology and Real Estate and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹40.4 Lakh; the largest is Biozen Biologics Private Limited at ₹20.3 Lakh (FY 2020).

DIN 07539752
Primary Designation Director
Industry Pharma
First Appointment 11 Jun 2016
Oldest Company Age 16 yrs
Largest company Biozen Biologics Private Limited · ₹20.3 Lakh (FY 2020)
Combined revenue ₹40.4 Lakh across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biozen Biologics Private Limited U21001TG2017PTC119213
Director14 Jun 20232017₹20.3 Lakh (FY 2020)Active
Kriscon Infratech Private Limited U45209TG2010PTC071210
Director11 Jun 20162010₹19.5 Lakh (FY 2020)Active
Terramax Properties Private Limited U70109TG2021PTC151429
Director14 May 20212021₹39,038 (FY 2023)Active
Director29 Jul 20222022₹26,861 (FY 2025)Active
Director13 Oct 20212021Active
Ssv Infratech India Limited U45209TG2010PLC067707
Director26 Mar 20172010Active

Directorship timeline

Open interactive timeline →
Innovera Pharmaceuticals Private Limited
Ssv Infratech India Limited
Kriscon Infratech Private Limited
Jcs Mobility Services Private Limited
Premium access

Shareholding and investment profile for Chandra Sekhar Rao Juvvadi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Sekhar Rao Juvvadi

Chandra Sekhar Rao Juvvadi currently holds 6 directorships: Biozen Biologics Private Limited (Director, since 14 Jun 2023, revenue ₹20.3 Lakh (FY 2020)); Kriscon Infratech Private Limited (Director, since 11 Jun 2016, revenue ₹19.5 Lakh (FY 2020)); Terramax Properties Private Limited (Director, since 14 May 2021, revenue ₹39,038 (FY 2023)); Innovera Pharmaceuticals Private Limited (Director, since 29 Jul 2022, revenue ₹26,861 (FY 2025)); Jcs Mobility Services Private Limited (Director, since 13 Oct 2021); and 1 more.

Chandra Sekhar Rao Juvvadi was first appointed on 11 Jun 2016 as Director at Kriscon Infratech Private Limited. The most recent appointment on record is 14 Jun 2023 at Biozen Biologics Private Limited.

The 4 current companies of Chandra Sekhar Rao Juvvadi that report revenue have a combined latest revenue of ₹40.4 Lakh: Biozen Biologics Private Limited ₹20.3 Lakh (FY 2020); Kriscon Infratech Private Limited ₹19.5 Lakh (FY 2020); Terramax Properties Private Limited ₹39,038 (FY 2023); Innovera Pharmaceuticals Private Limited ₹26,861 (FY 2025).

The current boards of Chandra Sekhar Rao Juvvadi's companies include Jaggavarapu Parvathidevi (Biozen Biologics Private Limited), Mankena Ajith Reddy (Biozen Biologics Private Limited), Mankena Sujith Reddy (Biozen Biologics Private Limited), Sanjeeva Reddy Jagavarappu (Biozen Biologics Private Limited), Srikanth Aitharaju (Biozen Biologics Private Limited), Nageshwar Rao Kotipally (Kriscon Infratech Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available